Physician profile
Brooke Weilage
NPI 1235638529
$2,538.40
in general payments reported to CMS, 2019-2025
24 companies · $428 in 2025
The $428 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $503 · 2022: $711 · 2023: $414 · 2024: $482 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $775.88 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $400.10 | 2021-2025 | Breztri |
| Novo Nordisk INC | $305.79 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $262.58 | 2021-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $201.71 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.23 | 2021-2022 | |
| Astellas Pharma US INC | $70.28 | 2023-2025 | Veozah |
| Merck Sharp & Dohme LLC | $58.15 | 2021-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Actelion Pharmaceuticals US, INC. | $47.17 | 2023-2025 | Uptravi, Opsumit |
| E.R. Squibb & Sons, L.L.C. | $39.40 | 2022 | |
| Janssen Pharmaceuticals, INC | $38.42 | 2021-2022 | |
| Genentech USA, INC. | $30.69 | 2021 | |
| Idorsia Pharmaceuticals US INC | $27.40 | 2022-2023 | Quviviq |
| Exact Sciences Corporation | $27.01 | 2023-2025 | Cologuard Collection Kit |
| Grifols USA, LLC | $24.19 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impel Pharmaceuticals INC. | $21.06 | 2023 | Trudhesa |
| Eisai INC. | $19.56 | 2021 | |
| Arbor Pharmaceuticals, INC. | $19.51 | 2021 | |
| Hologic Sales and Service, LLC | $18.88 | 2025 | Aptima, Thinprep 2000 Processor |
| Philips North America LLC | $17.48 | 2024 | (Ck7) Extended Holter |
| Antares Pharma, INC. | $17.23 | 2022 | |
| Esperion Therapeutics, INC. | $15.08 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $14.62 | 2022 | |
| Glaxosmithkline, LLC. | $11.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Weilage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.